Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in ...
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease ...
It's important to consult a healthcare professional for the best treatment plan based on the severity of your condition. Lichen planus cannot be prevented, but once it has developed, there are things ...
prurigo nodularis and lichen simplex chronicus. Psychogenic factors play a relevant role in both conditions, and they are often associated with depression and dissociative experiences. Hence ...
Helen Knight, director of medicines evaluation at NICE The treatment is for people with a type of blood cancer called acute lymphoblastic leukaemia (ALL). According to Leukaemia Care “Up to 90% of ...
Given the above statistics, it is important for us to cautiously consider stimulant treatment in adults with an eye toward the potential of diversion, misuse and toxicity. It is with the safety of ...
The sBLA is supported by data from a pivotal trial evaluating the efficacy and safety of Dupixent in 106 adults with moderate ... taper by week 16 (off OCS treatment and only treated with Dupixent ...
such as Dupixent for the treatment of adults with bullous pemphigoid as discussed in this press release as well as chronic pruritus of unknown origin, lichen simplex chronicus, and other potential ...
School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, P. R. China Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, ...
The financial burden associated with cancer in young adults is staggering, exceeding $1m 1 per patient when accounting for direct treatment costs and societal impacts. This economic strain is ...
(RTTNews) - Axsome Therapeutics, Inc. (AXSM) announced that the FDA has granted approval for SYMBRAVO for the acute treatment of migraine with or without aura in adults. SYMBRAVO combines two ...
One of the very few studies to examine subclinical herpes simplex virus (HSV) shedding in adults coinfected with HIV on highly ... for the participant to seek additional investigation or treatment.